Correlation Between InMed Pharmaceuticals and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMed Pharmaceuticals and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on InMed Pharmaceuticals and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Phio Pharmaceuticals.
Diversification Opportunities for InMed Pharmaceuticals and Phio Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between InMed and Phio is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between InMed Pharmaceuticals and Phio Pharmaceuticals
Considering the 90-day investment horizon InMed Pharmaceuticals is expected to generate 2.23 times more return on investment than Phio Pharmaceuticals. However, InMed Pharmaceuticals is 2.23 times more volatile than Phio Pharmaceuticals Corp. It trades about 0.02 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.04 per unit of risk. If you would invest 766.00 in InMed Pharmaceuticals on September 2, 2024 and sell it today you would lose (337.00) from holding InMed Pharmaceuticals or give up 43.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
InMed Pharmaceuticals vs. Phio Pharmaceuticals Corp
Performance |
Timeline |
InMed Pharmaceuticals |
Phio Pharmaceuticals Corp |
InMed Pharmaceuticals and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with InMed Pharmaceuticals and Phio Pharmaceuticals
The main advantage of trading using opposite InMed Pharmaceuticals and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.InMed Pharmaceuticals vs. Tff Pharmaceuticals | InMed Pharmaceuticals vs. Eliem Therapeutics | InMed Pharmaceuticals vs. Inhibrx | InMed Pharmaceuticals vs. Enliven Therapeutics |
Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |